IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2025.

Biopharma company Corcept Therapeutics (NASDAQ:CORT) in Q3 CY2025, but sales rose 13.7% year on year to $207.6 million. The ...

Former Los Angeles Kings right winger Arthur Kaliyev's ex-girlfriend details his alleged gambling addiction, massive debts to ...

Fellow shareholders, Axon delivered another record quarter, with revenue growing 31% year over year to $711 million — our ...

Q1 2026 Recurring & Other Revenue of $378.9 million, up 14% year-over-year Q1 2026 Total Revenue of $408.2 million, up 12% year-over-year ...

A new lawsuit alleges streaming giant Spotify turns a blind eye to vast networks of bots that inflate streaming figures to benefit megastars such as Drake at the expense of ...

San Antonio’s wave of restaurant closures isn’t just bad luck, according to the Texas Restaurant Association (TRA). A new ...

Q3 2025 Earnings Call November 4, 2025 8:30 AM ESTCompany ParticipantsPaul Taubman - Founder, Chairman & CEOHelen Meates - ...

New Drug Application for ziftomenib in adults with R/R NPM1-m AML remains under FDA Priority Review, with a PDUFA target action date of ...